Taivex Therapeutics Corporation;Development Center for Biotechnology
发明人:
Jiann-Jyh Huang,Shih-Hsien Chuang,Ying-Shuan Eda Lee,Yu-Ling Huang,Johnson Lau
申请号：
US13689590
公开号：
US08999983B2
申请日:
2012.11.29
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Compounds, compositions, and methods for modulation of Hec1/Nek2 interaction are provided. Such compounds disrupt Nek2/Hec1 binding and may be useful as chemotherapeutic agents for neoplastic diseases.
